New York State Common Retirement Fund Sells 60,703 Shares of Encompass Health Co. (NYSE:EHC)

New York State Common Retirement Fund reduced its position in shares of Encompass Health Co. (NYSE:EHC) by 38.0% in the fourth quarter, Holdings Channel reports. The firm owned 99,016 shares of the company’s stock after selling 60,703 shares during the quarter. New York State Common Retirement Fund’s holdings in Encompass Health were worth $6,606,000 as of its most recent SEC filing.

Several other large investors have also bought and sold shares of EHC. California Public Employees Retirement System lifted its position in Encompass Health by 160.5% in the 4th quarter. California Public Employees Retirement System now owns 515,717 shares of the company’s stock valued at $34,409,000 after acquiring an additional 317,730 shares in the last quarter. Duality Advisers LP bought a new position in shares of Encompass Health during the fourth quarter valued at $1,198,000. Handelsbanken Fonder AB boosted its position in shares of Encompass Health by 1.9% during the fourth quarter. Handelsbanken Fonder AB now owns 15,953 shares of the company’s stock valued at $1,064,000 after buying an additional 300 shares during the last quarter. Scissortail Wealth Management LLC bought a new stake in Encompass Health in the 4th quarter worth about $1,107,000. Finally, VELA Investment Management LLC raised its position in Encompass Health by 25.6% in the 4th quarter. VELA Investment Management LLC now owns 43,463 shares of the company’s stock worth $2,900,000 after buying an additional 8,856 shares during the last quarter. 97.25% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of analysts have recently commented on EHC shares. Mizuho lifted their price target on shares of Encompass Health from $93.00 to $95.00 and gave the stock a “buy” rating in a research note on Thursday, April 25th. Truist Financial boosted their target price on shares of Encompass Health from $82.00 to $86.00 and gave the company a “buy” rating in a research note on Friday, February 9th. Barclays raised their price target on Encompass Health from $101.00 to $108.00 and gave the stock an “overweight” rating in a research note on Thursday, April 25th. Royal Bank of Canada reiterated an “outperform” rating and set a $83.00 price objective on shares of Encompass Health in a research report on Friday, February 9th. Finally, Stephens reissued an “overweight” rating and issued a $85.00 target price on shares of Encompass Health in a research report on Tuesday, January 16th. Eight research analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Buy” and a consensus price target of $90.29.

Insider Buying and Selling at Encompass Health

In related news, CEO Mark J. Tarr sold 44,976 shares of the stock in a transaction dated Tuesday, April 30th. The stock was sold at an average price of $83.27, for a total transaction of $3,745,151.52. Following the completion of the sale, the chief executive officer now owns 554,098 shares in the company, valued at $46,139,740.46. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 2.10% of the company’s stock.

Encompass Health Stock Performance

NYSE:EHC opened at $83.21 on Friday. The stock has a 50-day simple moving average of $78.99 and a two-hundred day simple moving average of $71.41. The company has a debt-to-equity ratio of 1.14, a quick ratio of 1.28 and a current ratio of 1.37. Encompass Health Co. has a 52-week low of $57.55 and a 52-week high of $85.84. The firm has a market capitalization of $8.33 billion, a PE ratio of 22.49, a P/E/G ratio of 1.29 and a beta of 0.92.

Encompass Health (NYSE:EHC) last released its earnings results on Wednesday, April 24th. The company reported $1.12 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.93 by $0.19. The company had revenue of $1.32 billion during the quarter, compared to analyst estimates of $1.27 billion. Encompass Health had a net margin of 7.60% and a return on equity of 18.01%. The firm’s quarterly revenue was up 13.4% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.88 EPS. Analysts forecast that Encompass Health Co. will post 4.1 EPS for the current year.

Encompass Health Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Monday, July 15th. Shareholders of record on Monday, July 1st will be paid a $0.15 dividend. The ex-dividend date of this dividend is Monday, July 1st. This represents a $0.60 dividend on an annualized basis and a yield of 0.72%. Encompass Health’s payout ratio is presently 16.22%.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.